Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1503

1.

Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial.

Claessen SJ, Hazes JM, Huisman MA, van Zeben D, Luime JJ, Weel AE.

BMC Musculoskelet Disord. 2009 Jun 18;10:71. doi: 10.1186/1471-2474-10-71.

2.

A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.

Verstappen SM, van Albada-Kuipers GA, Bijlsma JW, Blaauw AA, Schenk Y, Haanen HC, Jacobs JW; Utrecht Rheumatoid Arthritis Cohort Study Group (SRU).

Ann Rheum Dis. 2005 Jan;64(1):38-43. Epub 2004 May 6.

3.

Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.

Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR.

Arthritis Rheum. 2008 May;58(5):1310-7. doi: 10.1002/art.23449.

4.

Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Ilonen J, Laasonen L, Kaipiainen-Seppänen O, Franzen P, Helve T, Koski J, Gripenberg-Gahmberg M, Myllykangas-Luosujärvi R, Leirisalo-Repo M; FIN-RACo Trial Group. FINnish Rheumatoid Arthritis Combination therapy.

Arthritis Rheum. 2002 Apr;46(4):894-8.

PMID:
11953964
5.

Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.

Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG.

Semin Arthritis Rheum. 2007 Oct;37(2):99-111. Epub 2007 Mar 27.

PMID:
17391739
6.

Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.

Quinn MA, Green MJ, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ, Conaghan PG, Emery P.

Arthritis Rheum. 2003 Nov;48(11):3039-45.

7.

Assessment and management of rheumatoid arthritis.

Haraoui B.

J Rheumatol Suppl. 2009 Jun;82:2-10. doi: 10.3899/jrheum.090124. Review. Erratum in: J Rheumatol. 2009 Aug;36(8):1851.

PMID:
19509324
8.

Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.

Verschueren P, Esselens G, Westhovens R.

Rheumatology (Oxford). 2008 Jan;47(1):59-64. Epub 2007 Nov 26.

PMID:
18039681
9.

How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.

Matteson EL, Weyand CM, Fulbright JW, Christianson TJ, McClelland RL, Goronzy JJ.

Rheumatology (Oxford). 2004 May;43(5):619-25. Epub 2004 Feb 24. Erratum in: Rheumatology (Oxford). 2004 Aug;43(8):1065.

PMID:
14983105
11.
12.

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.

Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M, Järvinen P, Ahonen J, Forsberg S, Leirisalo-Repo M; FIN-RACo Trial Group.

Arthritis Rheum. 2005 Jan;52(1):36-41.

13.

Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.

van Tuyl LH, Lems WF, Voskuyl AE, Kerstens PJ, Garnero P, Dijkmans BA, Boers M.

Ann Rheum Dis. 2008 Nov;67(11):1574-7. doi: 10.1136/ard.2008.090712. Epub 2008 Jul 14.

PMID:
18625629
14.

Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy.

Pincus T, O'Dell JR, Kremer JM.

Ann Intern Med. 1999 Nov 16;131(10):768-74. Review.

PMID:
10577301
15.

Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.

Alivernini S, Mazzotta D, Zoli A, Ferraccioli G.

Drugs Aging. 2009;26(5):395-402. doi: 10.2165/00002512-200926050-00003.

PMID:
19552491
16.

Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?

Cannella AC, O'Dell JR.

Curr Opin Rheumatol. 2003 May;15(3):185-92. Review.

PMID:
12707569
17.

Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria.

Kingsley GH, Khoshaba B, Smith CM, Choy EH, Scott DL.

Rheumatology (Oxford). 2005 May;44(5):629-32. Epub 2005 Feb 10.

PMID:
15705630
18.

Innovative treatment approaches for rheumatoid arthritis. Combination therapy.

Borigini MJ, Paulus HE.

Baillieres Clin Rheumatol. 1995 Nov;9(4):689-710. Review.

PMID:
8591649
19.

Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.

Allaart CF, Breedveld FC, Dijkmans BA.

J Rheumatol Suppl. 2007 Nov;80:25-33.

PMID:
17985420
20.

Progression in early rheumatoid arthritis.

Combe B.

Best Pract Res Clin Rheumatol. 2009 Feb;23(1):59-69. doi: 10.1016/j.berh.2008.11.006. Review.

PMID:
19233046

Supplemental Content

Support Center